Phenytoin Sodium Injection
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Phenytoin Sodium Injection is a sterile solution of Phenytoin Sodium with Propylene Glycol and Alcohol in Water for Injection. It contains NLT
95.0% and NMT 105.0% of the labeled amount of phenytoin sodium (C15H11N2NaO2).
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
Sample: Transfer an equivalent of 250 mg of phenytoin sodium from a volume of Injection to a separator containing 25 mL of water. Extract first with 50 mL of ethyl acetate and then with two additional 30-mL portions of ethyl acetate. Wash each extract with two 20-mL portions of sodium acetate solution (10 mg/mL). Evaporate the combined ethyl acetate extracts, and dry the residue of phenytoin at 105° to constant weight.
Acceptance criteria: Residue obtained from the Sample meets the requirements.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Mobile phase: Methanol and water (55:45)
Standard solution: 0.23 mg/mL of USP Phenytoin RS in Mobile phase
Sample solution: Nominally 0.25 mg/mL of phenytoin sodium from a volume of Injection equivalent to 250 mg of phenytoin sodium in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 25-cm; packing L1
Flow rate: 1.5 mL/min
Injection volume: 20 μL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of phenytoin sodium (C15H11N2NaO2) in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × (Mr1/Mr2) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Phenytoin RS in the Standard solution (mg/mL)
CU = nominal concentration of phenytoin sodium in the Sample solution (mg/mL)
Mr1 = molecular weight of phenytoin sodium, 274.25
Mr2 = molecular weight of phenytoin, 252.27
Acceptance criteria: 95.0%–105.0%
4 OTHER COMPONENTS
Alcohol and Propylene Glycol Content
Internal standard solution: 0.02 mL/mL of methanol and 0.04 mL/mL of ethylene glycol in water
Standard stock solution: 0.01 mL/mL of alcohol from USP Alcohol Determination–Alcohol RS and 0.04 mL/mL of USP Propylene Glycol RS in water
Standard solution: 0.005 mL/mL of alcohol and 0.02 mL/mL of propylene glycol prepared as follows. Pipet 5 mL each of Standard stock solution and Internal standard solution into a 10-mL volumetric flask.
Sample solution: 0.05 mL/mL of Injection in water prepared as follows. Pipet 5 mL of Injection and 50 mL of the Internal standard solution into a 100-mL volumetric flask, and dilute with water to volume.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 30-m × 0.53-mm (ID) capillary column with a 1-μm coating of G16 phase
Temperatures
Injection port: 240°
Detector: 250°
Column: See Table 1.
Table 1
| Initial Temperature (°) | Temperature Ramp (°/min) | Final Temperature (°) | Hold Time at Final Temperature (min) |
|---|---|---|---|
| 50 | 0 | 50 | 4 |
| 50 | 15 | 230 | 5 |
Carrier gas: Hydrogen or helium
Flow rate: 5 mL/min
Injection volume: 0.2 μL
Injection type: Split ratio, 10:1
System suitability
Sample: Standard solution
[Note - See Table 2 for the relative retention times.]
Suitability requirements
Resolution: NLT 5.0 between methanol and alcohol; NLT 5.0 between propylene glycol and ethylene glycol
Relative standard deviation: NMT 2.0% for each of the response ratios of alcohol to methanol and propylene glycol to ethylene glycol
Analysis
Samples: Standard solution and Sample solution
Calculate the alcohol content, as a percentage, in the portion of Injection taken:
Result = (RU/RS) × (CS/CU) × 100
RU = peak response ratio of alcohol to methanol from the Sample solution
RS = peak response ratio of alcohol to methanol from the Standard solution
CS = concentration of alcohol in the Standard solution (mL/mL)
CU = nominal concentration of the Injection in the Sample solution (mL/mL)
Calculate the propylene glycol content, as a percentage, in the portion of Injection taken:
Result = (RU/RS) × (CS/CU) × 100
RU = peak response ratio of propylene glycol to ethylene glycol from the Sample solution
RS = peak response ratio of propylene glycol to ethylene glycol from the Standard solution
CS = concentration of propylene glycol in the Standard solution (mL/mL)
CU = nominal concentration of the Injection in the Sample solution (mL/mL)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
|---|---|---|
| Methanol | 0.27 | – |
| Alcohol | 0.32 | 9.0–11.0 |
| Propylene glycol | 0.98 | 37.0–43.0 |
| Ethylene glycol | 1.0 | – |
aInternal standard included for peak identification purposes only.
5 SPECIFIC TESTS
Bacterial Endotoxins Test 〈85〉: It contains NMT 0.3 USP Endotoxin Unit/mg of phenytoin sodium.
pH 〈791〉: 10.0–12.3
Particulate Matter in Injections 〈788〉: It meets the requirements under small-volume injections.
Other Requirements: It meets the requirements under Injections and Implanted Drug Products 〈1〉.
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose or multiple-dose containers, preferably of Type I glass, at controlled room temperature.
Labeling: The label states the following: “Do not use the Injection if it is hazy or contains a precipitate.”
USP Reference Standards 〈11〉
USP Alcohol Determination–Alcohol RS
USP Phenytoin RS
USP Propylene Glycol RS

